Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink

被引：0
|
作者：
Suissa, Samy
Dell'Aniello, Sophie
Ernst, Pierre
机构：
[1] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
CHEST | 2020年 / 158卷 / 02期
关键词：
D O I：
10.1016/j.chest.2020.03.046
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：832 / 833
页数：2
相关论文
共 50 条
  • [41] Estimated lifetime effectiveness of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) versus dual LAMA/LABA and ICS/LABA therapies in moderate-to-very severe COPD
    Polyzoi, Maria
    Treharne, Catrin
    Mccrea, Charles
    Arnetorp, Sophie
    de Nigris, Enrico
    Holmgren, Ulf
    Miller, Paul
    Varghese, Precil
    Haughney, John
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [42] Ellithe: A prospective non-interventional Study to Assess the Quality of Life and Symptoms in COPD Patients receiving LAMA/LABA/ICS Triple Therapy
    Beeh, M. K.
    Scheithe, K.
    Brinkmann, R.
    PNEUMOLOGIE, 2022, 76 : S4 - S4
  • [43] DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS WITH COPD UTILIZING LAMA/LABA FIXED-DOSE COMBINATION THERAPY: A US DATABASE STUDY
    Ding, B.
    Kallenbach, L.
    Slipski, L.
    Wilk, A.
    O'Brien, D.
    Guranlioglu, D.
    THORAX, 2018, 73 : A233 - A233
  • [44] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chun-Yu Chen
    Sheng-Wei Pan
    Chia-Chen Hsu
    Jason J. Liu
    Hiraku Kumamaru
    Yaa-Hui Dong
    Respiratory Research, 24
  • [45] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chen, Chun-Yu
    Pan, Sheng-Wei
    Hsu, Chia-Chen
    Liu, Jason J.
    Kumamaru, Hiraku
    Dong, Yaa-Hui
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [46] Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
    Lee, Ye Jin
    Rhee, Chin Kook
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Lee, Doik
    Park, Yong Bum
    Kim, Youlim
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [47] Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naive to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials
    Buhl, Roland
    de la Hoz, Alberto
    Xue, Wenqiong
    Singh, Dave
    Ferguson, Gary T.
    ADVANCES IN THERAPY, 2020, 37 (10) : 4175 - 4189
  • [48] A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
    Ming, Simon Wan Yau
    Haughney, John
    Ryan, Dermot
    Small, Iain
    Lavorini, Federico
    Papi, Alberto
    Singh, Dave
    Halpin, David M. G.
    Hurst, John R.
    Patel, Shishir
    Ochel, Matthias
    Kocks, Janwillem
    Carter, Victoria
    Hardjojo, Antony
    Price, David B.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3093 - 3103
  • [49] The Effects of gradual Weaning of ICS on Exacerbation Risk and Lung Function in severe or very severe COPD Patients receiving LAMA plus LABA: The WISDOM-Study
    Magnussen, H.
    Disse, B.
    Rodriguez-Roisin, R.
    Kirsten, A.
    Watz, H.
    Tetzlaff, K.
    Towse, L.
    Finnigan, H.
    Dahl, R.
    Decramer, M.
    Chanez, P.
    Wouters, E.
    Calverley, P.
    INTERNIST, 2015, 56 : 47 - 48
  • [50] Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from India
    Salvi, Sundeep
    Deb, Ashish Kumar
    Agarwal, Mayank
    Tummuru, Venkateswara Reddy
    Kodgule, Rahul
    Hemalatha, V. S.
    Awasthi, Anil Kumar
    Suraj, K. P.
    Pavitran, Vinod Kumar
    Mourya, Shashi Prakash
    Thomas, Paul
    Vaidya, Abhijit
    Chhowala, Sushmeeta
    Gogtay, Jaideep
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 63
12345